Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Hypertens ; 2024 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-39248136

RESUMEN

OBJECTIVES: γδ T cells mediate angiotensin II (AngII)-induced hypertension and vascular injury. γδ T cells expressing specific T-cell receptor (TCR) variable (V) γ chains develop in several waves in the thymus and migrate to specific or diverse tissues. We hypothesized that γδ T cells expressing specific Vγ subtypes in perivascular tissue mediate AngII hypertensive effects. METHODS: C57BL/6J male mice were infused or not with AngII (490 ng/kg/min, subcutaneously) for 14 days. γδ T-cell Vγ subtypes were profiled by flow cytometry in the spleen, descending thoracic aorta with adherent perivascular adipose tissue (DTAo/PVAT) and mesenteric vessels (MV)/PVAT. Other sets of AngII-infused mice were injected with control or specific anti-Vγ6 or Vγ4 antibodies. Blood pressure (BP) was determined by telemetry, and mesenteric artery function and remodeling by pressurized myography. RESULTS: Vγ6/Vδ1+ γδ T cells represented more than 50% of the γδ T-cell Vγ subtypes in DTAo/PVAT and MV/PVAT, whereas Vγ1/2+, Vγ4+ and Vγ6/Vδ1+ γδ T cells were the most abundant Vγ subtypes in the spleen. The frequency of Vγ6/Vδ1+ γδ T cells was increased at least 1.5-fold in the spleen and DTAo/PVAT, and tended to increase in MV/PVAT by AngII. A majority of Vγ6/Vδ1+ γδ T cells were activated in perivascular tissues. Vγ6/Vδ1+ γδ T-cell neutralization caused a steeper BP elevation and greater mesenteric artery endothelial dysfunction in mice infused with AngII. This was associated with more than three-fold increase in activated Vγ6/Vδ1- γδ T cells in perivascular tissues. Depletion of Vγ4+ γδ T cells did not alter AngII detrimental effects. CONCLUSION: Vγ6/Vδ1+ γδ T cells reduce the BP elevation and endothelial dysfunction induced by AngII infusion.

3.
J Invest Dermatol ; 135(5): 1405-1414, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25233073

RESUMEN

Cutaneous squamous cell carcinoma (SCC) is the most prevalent invasive malignancy with metastatic potential. The epidermis is exposed to a variety of environmental DNA-damaging chemicals, principal among which are polyaromatic hydrocarbons (PAHs) ubiquitous in the environment, tobacco smoke, and broiled meats. Langerhans cells (LCs) comprise a network of dendritic cells situated adjacent to basal, suprabasal, and follicular infundibular keratinocytes that when mutated can give rise to SCC, and LC-intact mice are markedly more susceptible than LC-deficient mice to chemical carcinogenesis provoked by initiation with the model PAH, 7,12-dimethylbenz[a]anthracene (DMBA). LCs rapidly internalize and accumulate DMBA as numerous membrane-independent cytoplasmic foci. Repopulation of LC-deficient mice using fetal liver LC-precursors restores DMBA-induced tumor susceptibility. LC expression of p450 enzyme CYP1B1 is required for maximal rapid induction of DNA-damage within adjacent keratinocytes and their efficient neoplastic transformation; however, effects of tumor progression also attributable to the presence of LC were revealed as CYP1B1 independent. Thus, LCs make multifaceted contributions to cutaneous carcinogenesis, including via the handling and metabolism of chemical mutagens. Such findings suggest a cooperative carcinogenesis role for myeloid-derived cells resident within cancer susceptible epithelial tissues principally by influencing early events in malignant transformation.


Asunto(s)
Carcinogénesis/metabolismo , Carcinoma de Células Escamosas/metabolismo , Células de Langerhans/metabolismo , Mutágenos/efectos adversos , Neoplasias Cutáneas/metabolismo , 9,10-Dimetil-1,2-benzantraceno/efectos adversos , 9,10-Dimetil-1,2-benzantraceno/metabolismo , Animales , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/patología , Línea Celular , Transformación Celular Neoplásica/metabolismo , Transformación Celular Neoplásica/patología , Células Cultivadas , Citocromo P-450 CYP1B1/deficiencia , Citocromo P-450 CYP1B1/genética , Citocromo P-450 CYP1B1/metabolismo , Modelos Animales de Enfermedad , Queratinocitos/metabolismo , Queratinocitos/patología , Células de Langerhans/patología , Ratones , Ratones Noqueados , Mutágenos/metabolismo , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología
4.
Int J Nanomedicine ; 9: 5231-46, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25419128

RESUMEN

Targeting antigen to dendritic cells (DCs) is a powerful and novel strategy for vaccination. Priming or loading DCs with antigen controls whether subsequent immunity will develop and hence whether effective vaccination can be achieved. The goal of our present work was to increase the potency of DC-based antitumor vaccines by overcoming inherent limitations associated with antigen stability and cross-presentation. Nanoparticles prepared from the biodegradable polymer poly(lactic-co-glycolic acid) have been extensively used in clinical settings for drug delivery and are currently the subject of intensive investigation as antigen delivery vehicles for vaccine applications. Here we describe a nanoparticulate delivery system with the ability to simultaneously carry a high density of protein-based antigen while displaying a DC targeting ligand on its surface. Utilizing a targeting motif specific for the DC-associated surface ligand DEC-205, we show that targeted nanoparticles encapsulating a MART-127-35 peptide are both internalized and cross-presented with significantly higher efficiency than isotype control-coated nanoparticles in human cells. In addition, the DEC-205-labeled nanoparticles rapidly escape from the DC endosomal compartment and do not colocalize with markers of early (EEA-1) or late endosome/lysosome (LAMP-1). This indicates that encapsulated antigens delivered by nanoparticles may have direct access to the class I cytoplasmic major histocompatibility complex loading machinery, overcoming the need for "classical" cross-presentation and facilitating heightened DC stimulation of anti-tumor CD8(+) T-cells. These results indicate that this delivery system provides a flexible and versatile methodology to deliver melanoma-associated antigen to DCs, with both high efficiency and heightened potency.


Asunto(s)
Antígenos CD/inmunología , Vacunas contra el Cáncer/administración & dosificación , Células Dendríticas/inmunología , Ácido Láctico/química , Lectinas Tipo C/inmunología , Antígeno MART-1/administración & dosificación , Melanoma/inmunología , Nanopartículas/química , Ácido Poliglicólico/química , Receptores de Superficie Celular/inmunología , Presentación de Antígeno/efectos de los fármacos , Vacunas contra el Cáncer/inmunología , Humanos , Ácido Láctico/inmunología , Antígeno MART-1/inmunología , Melanoma/terapia , Antígenos de Histocompatibilidad Menor , Terapia Molecular Dirigida , Nanopartículas/administración & dosificación , Copolímero de Ácido Poliláctico-Ácido Poliglicólico
5.
Cutis ; 93(5): E17-20, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24897147

RESUMEN

Acute generalized exanthematous pustulosis (AGEP) is an acute sterile pustular eruption most commonly induced by medications. We present a case of AGEP with erythroderma following use of midodrine in a 58-year-old man. Although antibiotics are most commonly implicated in AGEP, we emphasize that nonantibiotic agents also may cause AGEP, which often manifests after a longer time interval compared to antibiotic-associated AGEP.


Asunto(s)
Pustulosis Exantematosa Generalizada Aguda/etiología , Midodrina/efectos adversos , Vasoconstrictores/efectos adversos , Pustulosis Exantematosa Generalizada Aguda/prevención & control , Humanos , Hipertensión/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Midodrina/administración & dosificación , Vasoconstrictores/administración & dosificación
6.
Transfus Apher Sci ; 50(3): 370-8, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24360371

RESUMEN

Extracorporeal Photochemotherapy (ECP) is a widely used therapy for cutaneous T cell lymphoma (CTCL). Although the mechanism of clinical action of ECP is not precisely established, previous studies have shown evidence of induction of dendritic cells (DCs). Here we show that, under flow conditions similar to those in post-capillary venules, ECP promotes platelet immobilization and activation, initiating stepwise receptor-ligand interactions with monocytes, which then differentiate into DC. These findings clarify how ECP directly stimulates DC maturation; suggest a new clinically applicable approach to the obtainment of DC; and identify a novel mechanism that may reflect physiological induction of DC.


Asunto(s)
Plaquetas/inmunología , Células Dendríticas/inmunología , Monocitos/inmunología , Fotoféresis , Activación Plaquetaria , Transducción de Señal , Adulto , Células Cultivadas , Femenino , Humanos , Masculino , Activación Plaquetaria/efectos de los fármacos , Activación Plaquetaria/efectos de la radiación , Transducción de Señal/efectos de los fármacos , Transducción de Señal/efectos de la radiación
7.
Transfus Apher Sci ; 50(3): 379-87, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24215840

RESUMEN

Extracorporeal photochemotherapy (ECP) is a widely used method for either immunization against cutaneous T cell lymphoma or immunosuppression of graft-versus-host disease and organ transplant rejection (OTR). Leukapheresed blood is routed through a chamber, in which 8-methoxypsoralen is activated by ultraviolet energy (PUVA), thereby causing DNA crosslinks in processed leukocytes. Return of ECP-processed mononuclear leukocytes to the patient then modulates aberrant T cell immunity. Since interaction with the ECP flow chamber induces monocyte-to-dendritic antigen presenting cell (DC) maturation, we examined the possibility that PUVA may direct the most heavily exposed monocytes to differentiate into tolerogenic DC, while the least exposed DC might remain immunogenic. Expression of the glucocorticoid-induced leucine zipper (GILZ) gene is a distinguishing marker of tolerogenic DC. We report that PUVA directly stimulates GILZ expression. PUVA-exposed DC up-regulated GILZ, down-regulated costimulatory CD80 and CD86, became resistant to Toll-like receptor-induced maturation, increased IL-10 production and decreased IL-12p70 production, all features of immunosuppressive DC. Knockdown of GILZ with siRNA reduced IL-10 and increased IL-12p70 production, demonstrating that GILZ is critical for this profile. PUVA-induction of GILZ expression by DC may help explain how ECP suppresses GVHD and OTR. Conversely, those ECP-processed monocytes minimally exposed to PUVA may mediate ECP's immunogenic effects.


Asunto(s)
Células Dendríticas/inmunología , Inmunomodulación , Metoxaleno/farmacología , Fotoféresis , Fármacos Fotosensibilizantes/farmacología , Factores de Transcripción/inmunología , Adulto , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/efectos de la radiación , Células Dendríticas/citología , Femenino , Humanos , Tolerancia Inmunológica/efectos de los fármacos , Tolerancia Inmunológica/efectos de la radiación , Inmunomodulación/efectos de los fármacos , Inmunomodulación/efectos de la radiación , Masculino , Terapia PUVA/métodos
10.
Science ; 335(6064): 104-8, 2012 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-22223807

RESUMEN

Polyaromatic hydrocarbons (PAHs) are prevalent, potent carcinogens, and 7,12-dimethylbenz[a]anthracene (DMBA) is a model PAH widely used to study tumorigenesis. Mice lacking Langerhans cells (LCs), a signatory epidermal dendritic cell (DC), are protected from cutaneous chemical carcinogenesis, independent of T cell immunity. Investigation of the underlying mechanism revealed that LC-deficient skin was relatively resistant to DMBA-induced DNA damage. LCs efficiently metabolized DMBA to DMBA-trans-3,4-diol, an intermediate proximal to oncogenic Hras mutation, and DMBA-treated LC-deficient skin contained significantly fewer Hras mutations. Moreover, DMBA-trans-3,4-diol application bypassed tumor resistance in LC-deficient mice. Additionally, the genotoxic impact of DMBA on human keratinocytes was significantly increased by prior incubation with human-derived LC. Thus, tissue-associated DC can enhance chemical carcinogenesis via PAH metabolism, highlighting the complex relation between immune cells and carcinogenesis.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/análogos & derivados , Carcinógenos/metabolismo , Carcinógenos/toxicidad , Carcinoma de Células Escamosas/inducido químicamente , Daño del ADN , Células de Langerhans/metabolismo , Neoplasias Cutáneas/inducido químicamente , 9,10-Dimetil-1,2-benzantraceno/metabolismo , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Hidrocarburo de Aril Hidroxilasas/metabolismo , Carcinoma de Células Escamosas/metabolismo , Transformación Celular Neoplásica , Células Cultivadas , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1B1 , Genes ras , Humanos , Queratinocitos/metabolismo , Queratinocitos/patología , Células de Langerhans/inmunología , Ratones , Ratones Transgénicos , Neoplasias Cutáneas/metabolismo , Linfocitos T/inmunología
11.
J Clin Immunol ; 31(4): 666-80, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21559932

RESUMEN

We examined the role of macrophage migration inhibitory factor (MIF) in the generation of the Th2 response using MIF-deficient mice in a model of epicutaneous sensitization to ovalbumin. Lymph node cells from sensitized MIF-deficient mice produce lower levels of Th2 cytokines after antigen challenge when compared to their wild-type counterparts. Sensitized mice lacking MIF show less pulmonary inflammation after intranasal antigen exposure. Mice deficient in CD74, the MIF receptor, also are unable to generate an inflammatory response to epicutaneous sensitization. Examination of the elicitation phase of the atopic response using DO11.10 OVA TCR transgenic animals shows that T cell proliferation and IL-2 production are strongly impaired in MIF-deficient T cells. This defect is most profound when both T cells and antigen-presenting cells are lacking MIF. These data suggest that MIF is crucial both for the sensitization and the elicitation phases of a Th2-type immune response in allergic disease.


Asunto(s)
Oxidorreductasas Intramoleculares/inmunología , Factores Inhibidores de la Migración de Macrófagos/inmunología , Células Th2/inmunología , Administración Cutánea , Administración Intranasal , Animales , Anticuerpos Monoclonales/administración & dosificación , Células Presentadoras de Antígenos/inmunología , Antígenos de Diferenciación de Linfocitos B/genética , Antígenos de Diferenciación de Linfocitos B/inmunología , Antígenos de Diferenciación de Linfocitos B/metabolismo , Células de la Médula Ósea , Complejo CD3/inmunología , Proliferación Celular , Citocinas/biosíntesis , Citocinas/inmunología , Femenino , Antígenos de Histocompatibilidad Clase II/genética , Antígenos de Histocompatibilidad Clase II/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Hipersensibilidad Inmediata , Inmunización , Interleucina-2/biosíntesis , Interleucina-2/inmunología , Oxidorreductasas Intramoleculares/deficiencia , Oxidorreductasas Intramoleculares/genética , Pulmón/inmunología , Pulmón/patología , Ganglios Linfáticos/inmunología , Factores Inhibidores de la Migración de Macrófagos/deficiencia , Factores Inhibidores de la Migración de Macrófagos/genética , Macrófagos , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Ovalbúmina/administración & dosificación , Ovalbúmina/inmunología , Neumonía/inmunología , Neumonía/patología
12.
Proc Natl Acad Sci U S A ; 108(8): 3330-5, 2011 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-21300860

RESUMEN

αß T-cell repertoire selection is mediated by peptide-MHC complexes presented by thymic epithelial or myeloid cells, and by lipid-CD1 complexes expressed by thymocytes. γδ T-cell repertoire selection, by contrast, is largely unresolved. Mice mutant for Skint-1, a unique Ig superfamily gene, do not develop canonical Vγ5Vδ1(+) dendritic epidermal T cells. This study shows that transgenic Skint-1, across a broad range of expression levels, precisely and selectively determines the Vγ5Vδ1(+) dendritic epidermal T-cell compartment. Skint-1 is expressed by medullary thymic epithelial cells, and unlike lipid-CD1 complexes, must be expressed by stromal cells to function efficiently. Its unusual transmembrane-cytoplasmic regions severely limit cell surface expression, yet increasing this or, conversely, retaining Skint1 intracellularly markedly compromises function. Each Skint1 domain appears nonredundant, including a unique decamer specifying IgV-domain processing. This investigation of Skint-1 biology points to complex events underpinning the positive selection of an intraepithelial γδ repertoire.


Asunto(s)
Epidermis/inmunología , Inmunoglobulinas/inmunología , Linfocitos T/inmunología , Animales , Células Dendríticas , Células Epidérmicas , Células Epiteliales , Expresión Génica/inmunología , Inmunoglobulinas/genética , Ratones , Ratones Transgénicos , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Subgrupos de Linfocitos T
13.
Blood ; 116(23): 4838-47, 2010 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-20720185

RESUMEN

Extracorporeal photochemotherapy (ECP) is widely used to treat cutaneous T-cell lymphoma, graft-versus-host disease, and allografted organ rejection. Its clinical and experimental efficacy in cancer immunotherapy and autoreactive disorders suggests a novel mechanism. This study reveals that ECP induces a high percentage of processed monocytes to enter the antigen-presenting dendritic cell (DC) differentiation pathway, within a single day, without added cytokines, as determined by enhanced expression of relevant genes. The resulting DCs are capable of processing and presentation of exogenous and endogenous antigen and are largely maturationally synchronized, as assessed by the level of expression of costimulatory surface molecules. Principal component analysis of the ECP-induced monocyte transcriptome reveals that activation or suppression of more than 1100 genes produces a reproducible distinctive molecular signature, common to ECP-processed monocytes from normal subjects, and those from patients. Because ECP induces normal monocytes to enter the DC differentiation pathway, this phenomenon is independent of disease state. The efficiency with which ECP stimulates new functional DCs supports the possibility that these cells participate prominently in the clinical successes of the treatment. Appropriately modified by future advances, ECP may potentially offer a general source of therapeutic DCs.


Asunto(s)
Diferenciación Celular , Células Dendríticas/citología , Expresión Génica , Fotoféresis , Presentación de Antígeno/efectos de los fármacos , Presentación de Antígeno/fisiología , Presentación de Antígeno/efectos de la radiación , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/efectos de la radiación , Separación Celular , Células Dendríticas/efectos de los fármacos , Células Dendríticas/efectos de la radiación , Citometría de Flujo , Expresión Génica/efectos de los fármacos , Expresión Génica/efectos de la radiación , Enfermedad Injerto contra Huésped/inmunología , Humanos , Inmunofenotipificación , Hibridación in Situ , Linfoma Cutáneo de Células T/inmunología , Monocitos/citología , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
15.
Semin Immunol ; 21(3): 110-20, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19369094

RESUMEN

Although studies of the skin have provided fundamental models for innate and adaptive immune surveillance of body surfaces, there remains relatively little understanding of the role that epithelial cells play in sensing infection and/or organ dysfunction, and the pathways available to them to communicate with local and systemic immune cells. In particular, evidence is emerging for a novel stress response initiated by local lymphocytes, rather than dendritic cells, and based on their recognition of epithelial stress-induced antigens. Its consequences are to sustain tissue integrity by providing immunoprotection and novel modes of immunoregulation, whereas its dysregulation may promote body surface immunopathologies.


Asunto(s)
Células de Langerhans/inmunología , Células de Langerhans/metabolismo , Piel/inmunología , Linfocitos T/inmunología , Animales , Presentación de Antígeno , Autoantígenos/inmunología , Comunicación Celular , Movimiento Celular , Citocinas/metabolismo , Humanos , Vigilancia Inmunológica , Queratinocitos/inmunología , Queratinocitos/metabolismo , Queratinocitos/patología , Activación de Linfocitos , Piel/patología , Estrés Fisiológico
16.
Arch Dermatol ; 145(2): 179-82, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19221263

RESUMEN

BACKGROUND: Palifermin is a recombinant human keratinocyte growth factor that is used to reduce the duration and severity of oral mucositis in patients undergoing hematopoietic stem cell transplantation after myelotoxic therapy. Cutaneous adverse reactions associated with keratinocyte growth factor are reported to be rash, pruritus, and erythema. OBSERVATIONS: After receiving palifermin following autologous hematopoietic stem cell transplantation and treatment with melphalan, a patient developed erythema and lichenoid papules that were distributed primarily in intertriginous areas. A biopsy specimen of the papules showed a striking resemblance to verrucae, but in situ hybridization studies were negative for human papillomavirus. Immunohistochemical staining with antibodies to Ki-67 and cytokeratin 5/6 showed increased keratinocyte proliferation in lesional skin. CONCLUSIONS: After treatment with palifermin, a papular eruption clinically resembling lichen planus or plane warts, with histologic features of verruca plana, and intertriginous erythema may occur. In this case, neither eruption required treatment, and spontaneous resolution was observed over days to weeks. Histopathologic staining patterns of Ki-67 and cytokeratin 5/6 may be useful in identifying adverse reactions to palifermin therapy.


Asunto(s)
Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/patología , Factor 7 de Crecimiento de Fibroblastos/efectos adversos , Mieloma Múltiple/terapia , Anciano , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Masculino , Mieloma Múltiple/patología , Proteínas Recombinantes , Estomatitis/tratamiento farmacológico , Estomatitis/etiología
17.
Immunol Invest ; 37(8): 798-821, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18991097

RESUMEN

To improve understanding of the forces that drive monocytes to transition into dendritic cells (Liyanage et al., 2002), we developed an experimental system that converts monocytes to DC by passage of leukocytes through a 400 microm silica bead column. The results demonstrate that overnight culture of column-treated monocytes causes a phenotypic conversion that is characteristically displayed by immature DC. These phenotypic changes were enhanced when the DC were loaded with apoptotic cells, leading to increased expression of the DC maturation-associated markers CD83, CD80 and the chemokine receptor CCR7. The DC demonstrated potent induction of allogeneic T cell proliferation and the capacity to activate autologous CD8(+) T cells. The CD8 T cells expressed augmented levels of perforin, IFN-gamma and TNF-alpha and mediated CTCL cell apoptosis. These studies demonstrate that physical contact with silica beads combined with loading of apoptotic tumor cells induces synchronized, rapid conversion of human monocytes to DC, which can efficiently stimulate CD8(+) T cells. These results may aid in the development of more efficient DC vaccines that can be loaded with the universe of antigens available in apoptotic tumor cells in a rapid, clinically practical fashion.


Asunto(s)
Presentación de Antígeno , Antígenos de Neoplasias/inmunología , Linfocitos T CD8-positivos/inmunología , Diferenciación Celular , Células Dendríticas/inmunología , Antígenos CD/biosíntesis , Antígenos CD/inmunología , Antígenos de Neoplasias/metabolismo , Apoptosis/inmunología , Antígeno B7-1/biosíntesis , Antígeno B7-1/inmunología , Linfocitos T CD8-positivos/metabolismo , Vacunas contra el Cáncer , Línea Celular Tumoral , Citotoxicidad Inmunológica , Células Dendríticas/patología , Humanos , Inmunoglobulinas/biosíntesis , Inmunoglobulinas/inmunología , Activación de Linfocitos , Linfoma de Células T/inmunología , Linfoma de Células T/patología , Mecanotransducción Celular , Glicoproteínas de Membrana/biosíntesis , Glicoproteínas de Membrana/inmunología , Monocitos/inmunología , Monocitos/patología , Perforina/biosíntesis , Receptores CCR7/biosíntesis , Receptores CCR7/inmunología , Dióxido de Silicio , Antígeno CD83
18.
Nat Genet ; 40(5): 656-62, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18408721

RESUMEN

B cells, alphabeta T cells and gammadelta T cells are conserved lymphocyte subtypes encoding their antigen receptors from somatically rearranged genes. alphabeta T cells undergo positive selection in the thymus by engagement of their T cell receptors (TCRs) with self-peptides presented by major histocompatibility complex molecules. The molecules that select gammadelta T cells are unknown. Vgamma5+Vdelta1+ cells comprise 90% of mouse epidermal gammadelta T cells. By mapping and genetic complementation using a strain showing loss of Vgamma5+Vdelta1+ cells due to a failure of thymic selection, we show that this defect is caused by mutation in Skint1, a newly identified gene expressed in thymus and skin that encodes a protein with immunoglobulin-like and transmembrane domains. Skint1 is the prototypic member of a rapidly evolving family of at least 11 genes in mouse, with greatest similarity to the butyrophilin genes. These findings define a new family of proteins mediating key epithelial-immune interactions.


Asunto(s)
Epidermis/inmunología , Inmunoglobulinas/genética , Inmunoglobulinas/inmunología , Familia de Multigenes , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Linfocitos T/inmunología , Secuencia de Aminoácidos , Animales , Codón sin Sentido , Ligamiento Genético , Haplotipos , Inmunoglobulinas/química , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Mutación , Conformación Proteica , Receptores de Antígenos de Linfocitos T gamma-delta/análisis
19.
Proc Natl Acad Sci U S A ; 104(16): 6770-5, 2007 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-17412837

RESUMEN

There is a longstanding but poorly understood epidemiologic link between inflammation and cancer. Consistent with this, we previously showed that alphabeta T cell deficiency can increase resistance to chemical carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene and promoted by phorbol 12-myristate 13-acetate. This provoked the hypothesis that alphabeta T cell deficiency removed T regulatory cells that limit the anti-tumor response or removed a specific tumor-promoting (T-pro) T cell population. Here we provide evidence for the latter, identifying a novel CD8(+) subset that is a candidate for T-pro cells. We demonstrate that CD8 cell-deficient mice show substantially less tumor incidence and progression to carcinoma, whereas susceptibility is restored by CD8(+) cell reconstitution. To characterize the putative T-pro cells, tumor-infiltrating lymphocytes were isolated from normal and CD4(-/-) mice, revealing an activated population of T cell receptor alphabeta(+)CD8(+)CD44(+)CD62L(-) cells expressing the inflammatory mediators IFNgamma, TNFalpha, and cyclooxygenase-2, but deficient in perforin, relative to recirculating cells of equivalent phenotype. This novel population of CD8(+) T cells has intriguing similarities with other lymphocytes that have been associated with tissue growth and invasiveness and has implications for inflammation-associated carcinogenesis, models of cancer immunosurveillance, and immunotherapeutic strategies.


Asunto(s)
Linfocitos T CD8-positivos/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Subgrupos de Linfocitos T/patología , Animales , Animales Recién Nacidos , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Síndromes de Inmunodeficiencia/genética , Síndromes de Inmunodeficiencia/metabolismo , Síndromes de Inmunodeficiencia/patología , Inmunofenotipificación , Linfocitos Infiltrantes de Tumor/inmunología , Linfocitos Infiltrantes de Tumor/metabolismo , Linfocitos Infiltrantes de Tumor/patología , Ratones , Ratones Noqueados , Receptores de Antígenos de Linfocitos T alfa-beta/biosíntesis , Receptores de Antígenos de Linfocitos T alfa-beta/deficiencia , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Neoplasias Cutáneas/genética , Subgrupos de Linfocitos T/metabolismo , Subgrupos de Linfocitos T/trasplante
20.
Nat Immunol ; 7(8): 843-50, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16829962

RESUMEN

Intraepithelial lymphocytes constitute a group of T cells that express mainly monospecific or oligoclonal T cell receptors (TCRs). Like adaptive TCR alphabeta+ T cells, intraepithelial lymphocytes, a subset enriched in TCR gammadelta+ T cells, are proposed to be positively selected by thymically expressed self agonists, yet no direct evidence for this exists at present. Mouse dendritic epidermal T cells are prototypic intraepithelial lymphocytes, displaying an almost monoclonal TCR gammadelta+ repertoire. Here we describe an FVB substrain of mice in which this repertoire was uniquely depleted, resulting in cutaneous pathology. This phenotype was due to failure of dendritic epidermal T cell progenitors to mature because of a heritable defect in a dominant gene used by the thymic stroma to 'educate' the natural, skin-associated intraepithelial lymphocyte repertoire to be of physiological use.


Asunto(s)
Células Dendríticas/citología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Piel/citología , Subgrupos de Linfocitos T/citología , Timo/inmunología , Animales , Diferenciación Celular/inmunología , Linaje de la Célula/inmunología , Células Dendríticas/inmunología , Citometría de Flujo , Ratones , Reacción en Cadena de la Polimerasa , Piel/inmunología , Células Madre/inmunología , Células del Estroma/inmunología , Subgrupos de Linfocitos T/inmunología , Timo/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...